From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: The receptor-interacting protein 1 odyssey

Immunological Reviews

Volumn 220, Issue 1, 2007, Pages 8-21

  Temkin, Vladislav ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Death receptor; JNK; NF B; RIP1; ROS

Indexed keywords

DEATH RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; AUTOIMMUNE DISEASE; CELL GROWTH; CELL SURVIVAL; DEGENERATIVE DISEASE; DIABETES MELLITUS; IMAGINATION; IMMUNE RESPONSE; INNATE IMMUNITY; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; DIABETES MELLITUS; HUMANS; IMMUNITY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOCHONDRIA; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, DEATH DOMAIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35748944844     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2007.00560.x     Document Type: Review

References (180)

1. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998 281 : 1305 1308.
2. Hsu LC, et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 2004 428 : 341 345.
3. Ma Y, Temkin V, Liu H, Pope RM. NF-kappaB protects macrophages from lipopolysaccharide-induced cell death: the role of caspase 8 and receptor-interacting protein. J Biol Chem 2005 280 : 41827 41834.
4. Suzuki T, et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 2005 33 : 231 247.
5. Siegmund SV, et al. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J 2007 21 : 2798 2806.
6. Blazquez C, et al. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 2006 20 : 2633 2635.
7. Sarfaraz S, Afaq F, Adhami VM, Mukhtar H. Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 2005 65 : 1635 1641.
8. Casanova ML, et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 2003 111 : 43 50.
9. Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 2005 41 : 1085 1095.
10. Saitoh M, Nagai K, Nakagawa K, Yamamura T, Yamamoto S, Nishizaki T. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem Pharmacol 2004 67 : 2005 2011.
11. Shneyvays V, et al. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Exp Cell Res 2000 257 : 111 126.
12. Li DH, et al. CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes. J Immunol 2006 176 : 5321 5328.
13. Vercammen D, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998 187 : 1477 1485.
14. Lin Y, et al. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 2004 279 : 10822 10828.
15. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005 120 : 649 661.
16. Pham CG, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004 119 : 529 542.
17. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007 26 : 1749 1760.
18. Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 2005 37 : 2478 2503.
19. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd edn. Oxford : Oxford University Press, 2002.
20. Brown GC, Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta 2004 1658 : 44 49.
21. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001 30 : 1191 1212.
22. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005 120 : 483 495.
23. Marx JL. Oxygen free radicals linked to many diseases. Science 1987 235 : 529 531.
24. Schrader M, Fahimi HD. Mammalian peroxisomes and reactive oxygen species. Histochem Cell Biol 2004 122 : 383 393.
25. Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003 112 : 481 490.
26. Le Bras M, Clement MV, Pervaiz S, Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 2005 20 : 205 219.
27. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996 87 : 565 576.
28. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973 134 : 707 716.
29. Nohl H. Generation of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin (Paris) 1994 52 : 199 204.
30. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000 25 : 502 508.
31. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003 552 : 335 344.
32. 2 production of heart mitochondria and aging rate are slower in canaries and parakeets than in mice: sites of free radical generation and mechanisms involved. Mech Ageing Dev 1998 103 : 133 146.
33. Starkov AA, et al. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 2004 24 : 7779 7788.
34. Zhang L, Yu L, Yu CA. Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J Biol Chem 1998 273 : 33972 33976.
35. Ricci JE, et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 2004 117 : 773 786.
36. Vahsen N, et al. AIF deficiency compromises oxidative phosphorylation. EMBO J 2004 23 : 4679 4689.
37. Ye H, et al. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 2002 9 : 680 684.
38. Miramar MD, et al. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 2001 276 : 16391 16398.
39. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000 29 : 222 230.
40. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 1997 416 : 15 18.
41. Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett 1998 423 : 275 280.
42. Arsenijevic D, et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000 26 : 435 439.
43. Cai J, Jones DP. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 1998 273 : 11401 11404.
44. Giorgio M, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005 122 : 221 233.
45. Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann NY Acad Sci 2000 908 : 219 225.
46. Okado-Matsumoto A, Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J Biol Chem 2001 276 : 38388 38393.
47. Nohl H, Jordan W. The metabolic fate of mitochondrial hydrogen peroxide. Eur J Biochem 1980 111 : 203 210.
48. Rigobello MP, Callegaro MT, Barzon E, Benetti M, Bindoli A. Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability. Free Radic Biol Med 1998 24 : 370 376.
49. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA. Detection of catalase in rat heart mitochondria. J Biol Chem 1991 266 : 22028 22034.
50. Beavis AD, Garlid KD. The mitochondrial inner membrane anion channel. Regulation by divalent cations and protons. J Biol Chem 1987 262 : 15085 15093.
51. Han D, Antunes F, Canali R, Rettori D, Cadenas E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J Biol Chem 2003 278 : 5557 5563.
52. Schonfeld P, Sayeed I, Bohnensack R, Siemen D. Fatty acids induce chloride permeation in rat liver mitochondria by activation of the inner membrane anion channel (IMAC). J Bioenerg Biomembr 2004 36 : 241 248.
53. Schrader M, Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta 2006 1763 : 1755 1766.
54. Landis GN, Tower J. Superoxide dismutase evolution and life span regulation. Mech Ageing Dev 2005 126 : 365 379.
55. Nohl H, Gille L. Lysosomal ROS formation. Redox Rep 2005 10 : 199 205.
56. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE 2006 2006 : re8.
57. Kuroda J, et al. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005 10 : 1139 1151.
58. Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. Biochem J 1972 128 : 617 630.
59. Baes M, et al. A mouse model for Zellweger syndrome. Nat Genet 1997 17 : 49 57.
60. Kirkham P, Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006 111 : 476 494.
61. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004 14 : 1 18.
62. Zangar RC, Davydov DR, Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 2004 199 : 316 331.
63. Caro AA, Cederbaum AI. Antioxidant properties of S-adenosyl-l-methionine in Fe(2+)-initiated oxidations. Free Radic Biol Med 2004 36 : 1303 1316.
64. Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 2003 43 : 149 173.
65. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004 4 : 181 189.
66. Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001 269 : 131 140.
67. Zhang AY, Yi F, Zhang G, Gulbins E, Li PL. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 2006 47 : 74 80.
68. Frey RS, Gao X, Javaid K, Siddiqui SS, Rahman A, Malik AB. Phosphatidylinositol 3-kinase gamma signaling through protein kinase Czeta induces NADPH oxidase-mediated oxidant generation and NF-kappaB activation in endothelial cells. J Biol Chem 2006 281 : 16128 16138.
69. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000 87 : 26 32.
70. Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause KH. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 2004 279 : 46065 46072.
71. Ueyama T, Geiszt M, Leto TL. Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol Cell Biol 2006 26 : 2160 2174.
72. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006 18 : 69 82.
73. 2+ activation of the NADPH oxidase 5 (NOX5). J Biol Chem 2004 279 : 18583 18591.
74. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001 3 : E255 E263.
75. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000 6 : 513 519.
76. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004 305 : 626 629.
77. Boya P, Roques B, Kroemer G. New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level. EMBO J 2001 20 : 4325 4331.
78. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999 399 : 483 487.
79. Rostovtseva TK, Tan W, Colombini M. On the role of VDAC in apoptosis: fact and fiction. J Bioenerg Biomembr 2005 37 : 129 142.
80. Lai JC, Tan W, Benimetskaya L, Miller P, Colombini M, Stein CA. A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDAC. Proc Natl Acad Sci USA 2006 103 : 7494 7499.
81. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007 9 : 550 555.
82. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 1999 274 : 5053 5060.
83. Nakagawa T, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005 434 : 652 658.
84. Petrosillo G, Ruggiero FM, Paradies G. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J 2003 17 : 2202 2208.
85. Temkin V, Huang Q, Liu H, Osada H, Pope RM. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol 2006 26 : 2215 2225.
86. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003 114 : 181 190.
87. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001 410 : 37 40.
88. Chang L, et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006 124 : 601 613.
89. Thome M, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997 386 : 517 521.
90. Werneburg N, Guicciardi ME, Yin XM, Gores GJ. TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am J Physiol Gastrointest Liver Physiol 2004 287 : G436 G443.
91. Kagedal K, Zhao M, Svensson I, Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 2001 359 : 335 343.
92. Stoka V, et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001 276 : 3149 3157.
93. Bidere N, Lorenzo HK, Carmona S, et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 2003 278 : 31401 31411.
94. Li JH, Pober JS. The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. J Immunol 2005 175 : 1858 1866.
95. Segui B, et al. CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. J Biol Chem 1999 274 : 37251 37258.
96. Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN. c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 2005 280 : 14507 14513.
97. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996 4 : 387 396.
98. Lin Y, et al. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol 2000 20 : 6638 6645.
99. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007 14 : 400 410.
100. Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 2005 30 : 151 159.
101. Lin Y, Devin A, Rodriguez Y, Liu ZG. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999 13 : 2514 2526.
102. Holler N, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000 1 : 489 495.
103. Stanger BZ, Leder P, Lee TH, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995 81 : 513 523.
104. Devin A, Lin Y, Liu ZG. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep 2003 4 : 623 627.
105. Ahmad M, et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997 57 : 615 619.
106. Vivarelli MS, McDonald D, Miller M, Cusson N, Kelliher M, Geha RS. RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation. J Exp Med 2004 200 : 399 404.
107. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002 297 : 1352 1354.
108. Majewski N, et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004 16 : 819 830.
109. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007 87 : 99 163.
110. Fiore C, et al. The mitochondrial ADP/ATP carrier: structural, physiological and pathological aspects. Biochimie 1998 80 : 137 150.
111. Baines CP, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005 434 : 658 662.
112. Schubert A, Grimm S. Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor. Cancer Res 2004 64 : 85 93.
113. Schulze K, Witzenbichler B, Christmann C, Schultheiss HP. Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovasc Res 1999 44 : 91 100.
114. Flierl A, Chen Y, Coskun PE, Samulski RJ, Wallace DC. Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse. Gene Ther 2005 12 : 570 578.
115. Hayakawa M, et al. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 2003 22 : 3356 3366.
116. 2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol 2006 26 : 140 154.
117. Matsuzawa A, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005 6 : 587 592.
118. Fan J, et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 2007 178 : 6573 6580.
119. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 2004 172 : 2522 2529.
120. Ryan KA, Smith MF Jr., Sanders MK, Ernst PB. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect Immun 2004 72 : 2123 2130.
121. Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 2004 173 : 3589 3593.
122. Lee NK, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005 106 : 852 859.
123. Papa S, et al. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 2004 6 : 146 153.
124. De Smaele E, et al. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001 414 : 308 313.
125. Tang G, et al. Inhibition of JNK activation through NF-kappaB target genes. Nature 2001 414 : 313 317.
126. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002 3 : 221 227.
127. Maeda S, Chang L, Li ZW, Luo JL, Leffert H, Karin M. IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity 2003 19 : 725 737.
128. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003 115 : 61 70.
129. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998 94 : 481 490.
130. Chen X, et al. Bid-independent mitochondrial activation in tumor necrosis factor alpha-induced apoptosis and liver injury. Mol Cell Biol 2007 27 : 541 553.
131. Yeh WC, et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000 12 : 633 642.
132. Tobiume K, et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001 2 : 222 228.
133. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 2006 13 : 730 737.
134. Nakajima A, et al. An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J 2006 25 : 5549 5559.
135. Liu Y, Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 2002 90 : 1259 1266.
136. Ventura JJ, Cogswell P, Flavell RA, Baldwin AS Jr., Davis RJ. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 2004 18 : 2905 2915.
137. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004 25 : 280 288.
138. Li ZW, et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999 189 : 1839 1845.
139. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 1999 284 : 321 325.
140. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998 281 : 1680 1683.
141. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996 274 : 782 784.
142. Asmis R, Begley JG. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ Res 2003 92 : e20 e29.
143. Makris C, et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 2000 5 : 969 979.
144. Park JM, et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis - CREB and NF-kappaB as key regulators. Immunity 2005 23 : 319 329.
145. Green DR. At the gates of death. Cancer Cell 2006 9 : 328 330.
146. Kuwana T, et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005 17 : 525 535.
147. Kim H, et al. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 2006 8 : 1348 1358.
148. Liu H, et al. TNF-alpha-induced apoptosis of macrophages following inhibition of NF-kappaB: a central role for disruption of mitochondria. J Immunol 2004 172 : 1907 1915.
149. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995 83 : 1243 1252.
150. Li X, Yang Y, Ashwell JD. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002 416 : 345 347.
151. Wertz IE, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004 430 : 694 699.
152. Liu N, et al. NF-kappaB protects from the lysosomal pathway of cell death. EMBO J 2003 22 : 5313 5322.
153. Jones PL, Ping D, Boss JM. Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB. Mol Cell Biol 1997 17 : 6970 6981.
154. Xu Y, et al. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 1999 18 : 709 722.
155. Melov S, et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998 18 : 159 163.
156. Starczynowski DT, et al. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity. Oncogene 2007 26 : 2685 2694.
157. Ferreira J. Effect of butylated hydroxyanisole on electron transport in rat liver mitochondria. Biochem Pharmacol 1990 40 : 677 684.
158. Amanullah A, et al. Cell signalling: cell survival and a Gadd45-factor deficiency. Nature 2003 424 : 741 discussion 742.
159. Szekanecz Z, Gaspar L, Koch AE. Angiogenesis in rheumatoid arthritis. Front Biosci 2005 10 : 1739 1753.
160. Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999 26 : 717 719.
161. Babior BM. Phagocytes and oxidative stress. Am J Med 2000 109 : 33 44.
162. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004 6 : 265 278.
163. Jaswal S, Mehta HC, Sood AK, Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003 338 : 123 129.
164. Miesel R, Murphy MP, Kroger H. Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma. Free Radic Res 1996 25 : 161 169.
165. Jikimoto T, et al. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2002 38 : 765 772.
166. Bokoch GM, Knaus UG. NADPH oxidases: not just for leukocytes anymore! Trends Biochem Sci 2003 28 : 502 508.
167. Dang PM, et al. A specific p47-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 2006 116 : 2033 2043.
168. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 2003 33 : 25 32.
169. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 2004 101 : 12646 12651.
170. Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLoS Med 2006 3 : e348.
171. Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2002 2 : 527 535.
172. Kim S, et al. NF-kappaB prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 2007 104 : 1913 1918.
173. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005 54 (Suppl.) : S97 S107.
174. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 : 813 820.
175. Pakala SV, Chivetta M, Kelly CB, Katz JD. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 1999 189 : 1053 1062.
176. Solinas G, Naugler W, Galimi F, Lee MS, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci USA 2006 103 : 16454 16459.
177. Hirosumi J, et al. A central role for JNK in obesity and insulin resistance. Nature 2002 420 : 333 336.
178. Jaeschke A, et al. Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes. Proc Natl Acad Sci USA 2005 102 : 6931 6935.
179. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 : 944 948.
180. Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006 25 : 4647 4662.